Patent · US Expired

Method for treating hepatitis B virus infections using 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil

US5246924A · kind A · utility

77Cited by

2References

4Claims

0Family size

Assignees

Sloan Kettering Institute for Cancer Research · US
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

Jack J. Fox · White Plains, US
Kyoichi A. Watanabe · Port Chester, US
Carlos Lopez · Carmel, US
Christian Trepo · Bron, FR

Key dates

Filing date	May 6, 1991
Grant date	Sep 21, 1993
Priority date	—
Expiry date	May 6, 2011

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/70
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a composition for, and a method of, treating a hepatitis viral infection in a subject using 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil [FEAU].

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.